M.A. Navarro-Puerto

ORCID: 0000-0002-1045-3607
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Potassium and Related Disorders
  • Chronic Disease Management Strategies
  • Liver Disease and Transplantation
  • Delphi Technique in Research
  • Soft tissue tumors and treatment
  • Sepsis Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Clinical Reasoning and Diagnostic Skills
  • Cardiac tumors and thrombi
  • Musculoskeletal synovial abnormalities and treatments
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Hemodynamic Monitoring and Therapy
  • COVID-19 Clinical Research Studies
  • Pharmaceutical industry and healthcare
  • Organ Transplantation Techniques and Outcomes

Hospital Universitario de Valme
2017-2024

Background: Immunomodulatory drugs have been used in patients with severe COVID-19. The objective of this study was to evaluate the effects two different strategies, based either on an interleukin-1 inhibitor, anakinra, or a JAK such as baricitinib, survival hospitalized COVID-19 pneumonia. Methods: Individuals admitted hospitals because were included if they fulfilled clinical, radiological, and laboratory criteria for moderate-to-severe disease. Patients classified according first...

10.3390/jcm10174019 article EN Journal of Clinical Medicine 2021-09-06

Purpose: Heart failure (HF) is a chronic, frequent and disabling condition but with modifiable course large potential for improving. The aim of this study was to validate the two available clinical prediction rules mortality at one year in patients primo-hospitalization decompensated HF: PREDICE AHEAD. secondary evaluate our setting changes pattern HF last decade hospitalized first episode disease. Patients methods: A prospective multicenter cohort study, which included 180 "de novo"...

10.2147/clep.s206017 article EN cc-by-nc Clinical Epidemiology 2019-07-01

Introduction. Our aim was to analyse the relation between serial values of indocyanine green plasma disappearance rate (ICG-PDR) with hospital mortality in first 48 hours ICU admission patients septic shock. Methods. A prospective observational study carried out over 12 months admitted Each patient underwent noninvasive determination ICG-PDR at 24 and LiMON® module. Follow-up performed until discharge or exitus. Results. 63 patients. Age 61.1±12.3 years. 60.3% men. SOFA score on 8.7±3.3,...

10.37201/req/029.2024 article EN cc-by-nc Revista Española de Quimioterapia 2024-06-27

Los tumores de la vena cava son excepcionales y mal pronóstico por su agresividad, demora diagnóstica escasas opciones terapéuticas. Se presenta el caso una paciente que ingresa en anasarca. La evolución clínica es desfavorable a pesar del tratamiento. Las técnicas imagen trabajo multidisciplinar fueron fundamentales para diagnóstico.

10.32818/reccmi.a2n3a14 article ES cc-by-nc-nd Revista Española de Casos Clínicos en Medicina Interna 2017-12-31

El síndrome de Budd-Chiari es el conjunto manifestaciones clínicas que aparece como consecuencia la trombosis venosa hepática, siendo lo más frecuente las venas suprahepáticas. Su etiología muy variada, debiéndose descartar presencia trombofilias hereditarias y adquiridas. Presentamos caso un varón 77 años, cardiópata con colitis ulcerosa, sin actividad inflamatoria en tratamiento mantenimiento mesalazina, remitido a consultas Medicina Interna por constitucional. Guiados exploración física...

10.32818/reccmi.a4n3a11 article ES Revista Española de Casos Clínicos en Medicina Interna 2019-12-01
Coming Soon ...